Company News
ALLpaQ and the Importance of our ISO 9001 Renewal
ALLpaQ is proud to confirm that we have successfully renewed our ISO 9001:2015 certification (Cert. 23250). This milestone wouldn’t have […]
Jan 26th, 2024
The Medicine and Healthcare products Regulatory Agency has underscored the need for strong controls around extractables and leachables in pharmaceutical development.
Dr Melaine Pires, senior pharmaceutical assessor at the MHRA, outlined existing regulatory guidelines to delegates at the Disposable Solutions for Biomanufacturing Conference in Munich, Germany.
Risks surrounding extractables and leachables included interfering with drug efficacy.
As such, Dr Pires said discussions were underway to harmonise legislation in key drug development regions around the world.